University of Rochester Vaccines to Prevent HIV Infection CRS (Site ID 31467) — Rochester, New York

University of Rochester Vaccines to Prevent HIV Infection CRS (Site ID 31467) is a clinical research site located in Rochester, New York, United States 14642.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Rochester Vaccines to Prevent HIV Infection CRS (Site ID 31467) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HIV.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Rochester Vaccines to Prevent HIV Infection CRS (Site ID 31467)?

University of Rochester Vaccines to Prevent HIV Infection CRS (Site ID 31467) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Rochester Vaccines to Prevent HIV Infection CRS (Site ID 31467) conducted?

University of Rochester Vaccines to Prevent HIV Infection CRS (Site ID 31467) has 1 clinical trials on record, with 1 currently active. Their work covers HIV.

Is University of Rochester Vaccines to Prevent HIV Infection CRS (Site ID 31467) accredited by Crixeo Health?

University of Rochester Vaccines to Prevent HIV Infection CRS (Site ID 31467) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Rochester Vaccines to Prevent HIV Infection CRS (Site ID 31467)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.